Structural and Regulatory Changes in PBP4 Trigger Decreased β-Lactam Susceptibility in Enterococcus faecalis
- PMID: 29615500
- PMCID: PMC5885037
- DOI: 10.1128/mBio.00361-18
Structural and Regulatory Changes in PBP4 Trigger Decreased β-Lactam Susceptibility in Enterococcus faecalis
Abstract
Enterococcus faecalis strains resistant to penicillin and ampicillin are rare and have been associated with increases in quantities of low-affinity penicillin-binding protein 4 (PBP4) or with amino acid substitutions in PBP4. We report an E. faecalis strain (LS4828) isolated from a prosthetic knee joint that was subjected to long-term exposure to aminopenicillins. Subsequent cultures yielded E. faecalis with MICs of penicillins and carbapenems higher than those for wild-type strain E. faecalis JH2-2. Sequence analysis of the pbp4 gene of LS4828 compared to that of JH2-2 revealed two point mutations with amino acid substitutions (V223I, A617T) and deletion of an adenine from the region upstream of the predicted pbp4 -35 promoter sequence (UP region). Purified PBP4 from LS4828 exhibited less affinity for Bocillin FL than did PBP4 from JH2-2, which was recapitulated by purified PBP4 containing only the A617T mutation. Differential scanning fluorimetry studies showed that the LS4828 and A617T variants are destabilized compared to wild-type PBP4. Further, reverse transcription-PCR indicated increased transcription of pbp4 in LS4828 and Western blot analysis with polyclonal PBP4 antibody revealed greater quantities of PBP4 in LS4828 than in JH2-2 lysates and membrane preparations. Placing the promoter regions from LS4828 or JH2-2 upstream of a green fluorescent protein reporter gene confirmed that the adenine deletion was associated with increased transcription. Together, these data suggest that the reduced susceptibility to β-lactam antibiotics observed in E. faecalis LS4828 results from a combination of both increased expression and remodeling of the active site, resulting in reduced affinity for penicillins and carbapenems.IMPORTANCEEnterococcus faecalis is an important cause of community-acquired and nosocomial infections and creates therapeutic dilemmas because of its frequent resistance to several classes of antibiotics. We report an E. faecalis strain with decreased ampicillin and imipenem susceptibility isolated after prolonged courses of aminopenicillin therapy for a prosthetic joint infection. Its reduced susceptibility is attributable to a combination of increased quantities of low-affinity PBP4 and an amino acid substitution in proximity to the active site that destabilizes the protein. Our findings provide a cautionary tale for clinicians who elect to "suppress" infections in prosthetic joints and offer novel insights into the interaction of β-lactam antibiotics with low-affinity PBP4. These insights will help inform future efforts to develop therapeutics capable of inhibiting clinical enterococcal strains.
Keywords: Enterococcus; antibiotic resistance; penicillin-binding proteins.
Copyright © 2018 Rice et al.
Figures






Similar articles
-
Penicillin-Binding Proteins and Alternative Dual-Beta-Lactam Combinations for Serious Enterococcus faecalis Infections with Elevated Penicillin MICs.Antimicrob Agents Chemother. 2023 Feb 16;67(2):e0087122. doi: 10.1128/aac.00871-22. Epub 2023 Jan 31. Antimicrob Agents Chemother. 2023. PMID: 36719223 Free PMC article.
-
Impact of PBP4 Alterations on β-Lactam Resistance and Ceftobiprole Non-Susceptibility Among Enterococcus faecalis Clinical Isolates.Front Cell Infect Microbiol. 2022 Jan 20;11:816657. doi: 10.3389/fcimb.2021.816657. eCollection 2021. Front Cell Infect Microbiol. 2022. PMID: 35127564 Free PMC article.
-
Evaluation of polymorphisms in pbp4 gene and genetic diversity in penicillin-resistant, ampicillin-susceptible Enterococcus faecalis from hospitals in different states in Brazil.FEMS Microbiol Lett. 2016 Apr;363(7):fnw044. doi: 10.1093/femsle/fnw044. Epub 2016 Feb 22. FEMS Microbiol Lett. 2016. PMID: 26903013
-
Mechanisms of resistance to imipenem and ampicillin in Enterococcus faecalis.Antimicrob Agents Chemother. 2005 Jul;49(7):2954-8. doi: 10.1128/AAC.49.7.2954-2958.2005. Antimicrob Agents Chemother. 2005. PMID: 15980374 Free PMC article.
-
Treatment of Enterococcus faecalis Infective Endocarditis: A Continuing Challenge.Antibiotics (Basel). 2023 Apr 4;12(4):704. doi: 10.3390/antibiotics12040704. Antibiotics (Basel). 2023. PMID: 37107066 Free PMC article. Review.
Cited by
-
Unveiling the Relationship between Ceftobiprole and High-Molecular-Mass (HMM) Penicillin-Binding Proteins (PBPs) in Enterococcus faecalis.Antibiotics (Basel). 2024 Jan 9;13(1):65. doi: 10.3390/antibiotics13010065. Antibiotics (Basel). 2024. PMID: 38247624 Free PMC article.
-
Meropenem plus Ceftaroline Is Active against Enterococcus faecalis in an In Vitro Pharmacodynamic Model Using Humanized Dosing Simulations.Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0042622. doi: 10.1128/aac.00426-22. Epub 2022 Sep 26. Antimicrob Agents Chemother. 2022. PMID: 36154173 Free PMC article.
-
Antimicrobial Resistance Profiles of Enterococcus faecium and Enterococcus faecalis Isolated from Healthy Dogs and Cats in South Korea.Microorganisms. 2023 Dec 15;11(12):2991. doi: 10.3390/microorganisms11122991. Microorganisms. 2023. PMID: 38138136 Free PMC article.
-
The Enterococcus: a Model of Adaptability to Its Environment.Clin Microbiol Rev. 2019 Jan 30;32(2):e00058-18. doi: 10.1128/CMR.00058-18. Print 2019 Mar 20. Clin Microbiol Rev. 2019. PMID: 30700430 Free PMC article. Review.
-
Multiple Low-Reactivity Class B Penicillin-Binding Proteins Are Required for Cephalosporin Resistance in Enterococci.Antimicrob Agents Chemother. 2020 Mar 24;64(4):e02273-19. doi: 10.1128/AAC.02273-19. Print 2020 Mar 24. Antimicrob Agents Chemother. 2020. PMID: 32041714 Free PMC article.
References
-
- Fernández-Hidalgo N, Almirante B, Gavaldà J, Gurgui M, Peña C, de Alarcón A, Ruiz J, Vilacosta I, Montejo M, Vallejo N, López-Medrano F, Plata A, López J, Hidalgo-Tenorio C, Gálvez J, Sáez C, Lomas JM, Falcone M, de la Torre J, Martínez-Lacasa X, Pahissa A. 2013. Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis. Clin Infect Dis 56:1261–1268. doi:10.1093/cid/cit052. - DOI - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases